Atrial and Ventricular Septal Defect Closure Device Market Size, Share & Trends Analysis | Global | 2026-2032 | MedCore

Year: 2026
Scope: 10 Years
Region: Global
Published Date: 12/24/2025
Type: MedCore

Product Description

The global atrial and ventricular septal defect closure device market was valued at $190.9 million in 2025. This is expected to increase over the forecast period at a CAGR of 1.8% to reach 215.7 million by 2032.

The full report suite on the global market for atrial and ventricular septal defect closure devices includes devices that treat atrial and ventricular septal defects percutaneously by inserting a device through the defect, which expands and forms a seal around the defect. Many of these devices allow heart tissue to grow over the device with time.

The report includes data for 65+ countries across 7 different regions which include North America, Latin America, Western Europe, Central & Eastern Europe, Middle East, Asia-Pacific and Africa.

Data Types Included

Unit Sales, Average Selling Prices, Market Size & Growth Trends
Procedure Numbers
Market Drivers & Limiters
Market Forecasts Until 2032, and Historical Data to 2022
Recent Mergers & Acquisitions
Company Profiles and Product Portfolios
Leading Competitors

Global Atrial and Ventricular Septal Defect Closure Device Market Trends

Global Atrial and Ventricular Septal Defect Closure Market Growth, 2022-2032

The atrial and ventricular septal defect closure device market is constrained by the relatively low incidence of ventricular septal defects (VSDs), which limits overall procedural volumes. Although advancements in prenatal and postnatal diagnostic techniques have improved detection rates, the absolute number of treatable cases remains limited. Furthermore, declining global birth rates, particularly in developed markets, are expected to further reduce the addressable patient population over the forecast period.

Global Atrial and Ventricular Septal Defect Closure Device Market Share Insights

Top Global Atrial and Ventricular Septal Defect Closure Device Market Leaders

Abbott was the leading competitor in the global atrial and ventricular septal defect closure device market. The company offers the Amplatzer™ line that includes both ASD and VSD closure devices. There are a limited number of companies with a global presence, allowing Abbott to keep its market share over the coming years.
Gore was the second-leading competitor in the global atrial and ventricular septal defect closure device market in 2025. The company offers its Gore® Cardioform Septal Occluder. Operating only in the atrial market regionally, the company may lose some market share to smaller local companies.

Global Atrial and Ventricular Septal Defect Closure Device Market Segmentation Summary

Atrial Septal Defect Closure Device Market
Ventricular Septal Defect Closure Device Market

Research Scope Summary

Report Attribute	Details
Regions	North America (Canada, United States) Latin America (Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom) Central & Eastern Europe (Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam) Africa (Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)
Base Year	2025
Forecast	2026-2032
Historical Data	2022-2024
Quantitative Coverage	Procedure Numbers, Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, Average Selling Prices.
Qualitative Coverage	Market Growth Trends, Market Limiters, Competitive Analysis for Top Competitors, Mergers & Acquisitions, Emerging Markets & Technologies, Key Analysis Updates.
Data Sources	Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database.

CONTACT US FOR ADDITIONAL INFORMATION

For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.

FREE Sample Report

List Of Figures

List Of Charts

Research Methodology

Step 1: Project Initiation & Team Selection

Step 2: Prepare Data Systems And Perform Secondary Research

Step 3: Preparation For Interviews & Questionnaire Design

Step 4: Performing Primary Research

Step 5: Research Analysis: Establishing Baseline Estimates

Step 6: Market Forecast And Analysis

Step 7: Identify Strategic Opportunities

Step 8: Final Review And Market Release

Step 9: Customer Feedback And Market Monitoring

Impact Of Global Tariffs

Disease Overview

3.1 Basic Anatomy

3.2 Disease Treatments & Diagnostics

3.2.1 Coronary Artery Disease

3.2.2 Myocardial Infarction

3.2.3 Angina Pectoris

3.2.4 Heart Valve Disease

3.2.5 Congestive Heart Failure

3.2.6 Aortic Stenosis

3.2.7 Degenerative/Functional Mitral Regurgitation

3.3 Patient Demographics

3.3.1 General Statistics

3.3.2 Coronary Artery Disease

3.3.3 Myocardial Infarction

3.3.4 Angina Pectoris

3.3.5 Heart Valve Disease

3.3.6 Congestive Heart Failure

Atrial & Ventricular Septal Defect Closure Device Market

23.1 Executive Summary

23.1.1 Global Atrial & Ventricular Septal Defect Closure Device Market Overview

23.1.2 Competitive Analysis

23.1.3 Procedures Included

23.1.4 Markets Included

23.1.5 Regions Included

23.2 Introduction

23.3 Procedure Numbers

23.3.1 Total Atrial And Ventricular Septal Defect Closure Procedures

23.3.2 Atrial Septal Defect Closure Procedures

23.3.3 Ventricular Septal Defect Closure Procedures

23.4 Market Overview

23.4.1 By Segment

23.4.2 By Region

23.5 Market Analysis And Forecast

23.5.1 Total Atrial & Ventricular Septal Defect Closure Device Market

23.5.2 Atrial Septal Defect Closure Device Market

23.5.3 Ventricular Septal Defect Closure Device Market

23.6 Drivers And Limiters

23.6.1 Market Drivers

23.6.2 Market Limiters

23.7 Competitive Market Share Analysis

Abbreviations

Companies Included

Abbott	Heart Care India
Abiomed	Jarvik Heart
Andocor	JC Medical
AndraTec	JenaValve Technologies
Artivion	Labcor
AtriCure	Laser Engineering
B. Braun	LeMaitre Vascular
Balance Medical	Lepu Medical
Balt Extrusion	Lifetech Scientific
Becton Dickinson	LivaNova
Beijing Jingjing Medical Equipment	local companies
Biosense Webster	Med Europe
Biosensors	MediValve
Biostable	Medtronic
Boston Scientific	Meril Life Sciences
Braile Biomedica	Minntech
Carag	Nipro
Cardia	NuMed
Cardiac Dimensions	Occlutech
Cardio Medical	Opsens
CARMAT	P&F Products & Features
Chase Medical	Peijia Medical
Chinabridge (Shenzhen) Medical Technology	Reliant Heart
Cingular Biotech	Saphena Medical
Claret Medical	Sarstedt
Comed BV	Senko Medical
Cook Medical	Simeks Medical
Corcym	SMT
Edwards Lifesciences	Syncardia
EUROSETS	Terumo
Fresenius	Tokai Medical Products
Genesee Biomedical	Toray
Getinge	Vascular Interventions
Gore	Venus Medtech Zeon Medical
Haemonetics

Chart List

Chart 23-1: Atrial & Ventricular Septal Defect Closure Device Market, Global, 2025 & 2032

Chart 23-2: Atrial & Ventricular Septal Defect Closure Device Procedures, Global, 2025

Chart 23-3: Atrial And Ventricular Septal Defect Closure Procedures By Segment, Global, 2022 – 2032

Chart 23-4: Atrial & Ventricular Septal Defect Closure Device Market By Segment, Global, 2022 – 2032

Chart 23-5: Atrial & Ventricular Septal Defect Closure Device Market By Region, Global, 2022 – 2032

Chart 23-6: Leading Competitors, Atrial & Ventricular Septal Defect Closure Device Market, Global, 2025

Figure List

Figure 23-1: Atrial & Ventricular Septal Defect Closure Procedures Covered

Figure 23-2: Atrial & Ventricular Septal Defect Closure Device Markets Covered

Figure 23-3: Atrial & Ventricular Septal Defect Closure Device Market Regions Covered, Global (1 Of 2)

Figure 23-4: Atrial & Ventricular Septal Defect Closure Device Market Regions Covered, Global (2 Of 2)

Figure 23-5: Atrial And Ventricular Septal Defect Closure Procedures By Type, Global, 2022 – 2032

Figure 23-6: Atrial And Ventricular Septal Defect Closure Procedures By Region, Global, 2022 – 2032

Figure 23-7: Atrial And Ventricular Septal Defect Closure Procedures By Country, North America, 2022 – 2032

Figure 23-8: Atrial And Ventricular Septal Defect Closure Procedures By Country, Latin America, 2022 – 2032 (1 Of 2)

Figure 23-9: Atrial And Ventricular Septal Defect Closure Procedures By Country, Latin America, 2022 – 2032 (2 Of 2)

Figure 23-10: Atrial And Ventricular Septal Defect Closure Procedures By Country, Western Europe, 2022 – 2032

Figure 23-11: Atrial And Ventricular Septal Defect Closure Procedures By Country, Central & Eastern Europe, 2022 – 2032 (1 Of 2)

Figure 23-12: Atrial And Ventricular Septal Defect Closure Procedures By Country, Central & Eastern Europe, 2022 – 2032 (2 Of 2)

Figure 23-13: Atrial And Ventricular Septal Defect Closure Procedures By Country, Middle East, 2022 – 2032

Figure 23-14: Atrial And Ventricular Septal Defect Closure Procedures By Country, Asia-Pacific, 2022 – 2032 (1 Of 3)

Figure 23-15: Atrial And Ventricular Septal Defect Closure Procedures By Country, Asia-Pacific, 2022 – 2032 (2 Of 3)

Figure 23-16: Atrial And Ventricular Septal Defect Closure Procedures By Country, Asia-Pacific, 2022 – 2032 (3 Of 3)

Figure 23-17: Atrial And Ventricular Septal Defect Closure Procedures By Country, Africa, 2022 – 2032

Figure 23-18: Atrial Septal Defect Closure Procedures By Region, Global, 2022 – 2032

Figure 23-19: Atrial Septal Defect Closure Procedures By Country, North America, 2022 – 2032

Figure 23-20: Atrial Septal Defect Closure Procedures By Country, Latin America, 2022 – 2032 (1 Of 2)

Figure 23-21: Atrial Septal Defect Closure Procedures By Country, Latin America, 2022 – 2032 (2 Of 2)

Figure 23-22: Atrial Septal Defect Closure Procedures By Country, Western Europe, 2022 – 2032

Figure 23-23: Atrial Septal Defect Closure Procedures By Country, Central & Eastern Europe, 2022 – 2032 (1 Of 2)

Figure 23-24: Atrial Septal Defect Closure Procedures By Country, Central & Eastern Europe, 2022 – 2032 (2 Of 2)

Figure 23-25: Atrial Septal Defect Closure Procedures By Country, Middle East, 2022 – 2032

Figure 23-26: Atrial Septal Defect Closure Procedures By Country, Asia-Pacific, 2022 – 2032 (1 Of 3)

Figure 23-27: Atrial Septal Defect Closure Procedures By Country, Asia-Pacific, 2022 – 2032 (2 Of 3)

Figure 23-28: Atrial Septal Defect Closure Procedures By Country, Asia-Pacific, 2022 – 2032 (3 Of 3)

Figure 23-29: Atrial Septal Defect Closure Procedures By Country, Africa, 2022 – 2032

Figure 23-30: Ventricular Septal Defect Closure Procedures By Region, Global, 2022 – 2032

Figure 23-31: Ventricular Septal Defect Closure Procedures By Country, North America, 2022 – 2032

Figure 23-32: Ventricular Septal Defect Closure Procedures By Country, Latin America, 2022 – 2032 (1 Of 2)

Figure 23-33: Ventricular Septal Defect Closure Procedures By Country, Latin America, 2022 – 2032 (2 Of 2)

Figure 23-34: Ventricular Septal Defect Closure Procedures By Country, Western Europe, 2022 – 2032

Figure 23-35: Ventricular Septal Defect Closure Procedures By Country, Central & Eastern Europe, 2022 – 2032 (1 Of 2)

Figure 23-36: Ventricular Septal Defect Closure Procedures By Country, Central & Eastern Europe, 2022 – 2032 (2 Of 2)

Figure 23-37: Ventricular Septal Defect Closure Procedures By Country, Middle East, 2022 – 2032

Figure 23-38: Ventricular Septal Defect Closure Procedures By Country, Asia-Pacific, 2022 – 2032 (1 Of 3)

Figure 23-39: Ventricular Septal Defect Closure Procedures By Country, Asia-Pacific, 2022 – 2032 (2 Of 3)

Figure 23-40: Ventricular Septal Defect Closure Procedures By Country, Asia-Pacific, 2022 – 2032 (3 Of 3)

Figure 23-41: Ventricular Septal Defect Closure Procedures By Country, Africa, 2022 – 2032

Figure 23-42: Atrial & Ventricular Septal Defect Closure Device Market By Segment, Global, 2022 – 2032 (US$M)

Figure 23-43: Atrial & Ventricular Septal Defect Closure Device Market By Region, Global, 2022 – 2032 (US$M)

Figure 23-44: Atrial & Ventricular Septal Defect Closure Device Market, Global, 2022 – 2032

Figure 23-45: Units Sold By Region, Atrial & Ventricular Septal Defect Closure Device Market, Global, 2022 – 2032

Figure 23-46: Average Selling Price By Region, Atrial & Ventricular Septal Defect Closure Device Market, Global, 2022 – 2032 (US$)

Figure 23-47: Market Value By Region Atrial & Ventricular Septal Defect Closure Device Market, Global, 2022 – 2032 (US$M)

Figure 23-48: Atrial Septal Defect Closure Device Market, Global, 2022 – 2032

Figure 23-49: Units Sold By Region, Atrial Septal Defect Closure Device Market, Global, 2022 – 2032

Figure 23-50: Average Selling Price By Region, Atrial Septal Defect Closure Device Market, Global, 2022 – 2032 (US$)

Figure 23-51: Market Value By Region, Atrial Septal Defect Closure Device Market, Global, 2022 – 2032 (US$M)

Figure 23-52: Ventricular Septal Defect Closure Device Market, Global, 2022 – 2032

Figure 23-53: Units Sold By Region, Ventricular Septal Defect Closure Device Market, Global, 2022 – 2032

Figure 23-54: Average Selling Price By Region, Ventricular Septal Defect Closure Device Market, Global, 2022 – 2032 (US$)

Figure 23-55: Market Value By Region, Ventricular Septal Defect Closure Device Market, Global, 2022 – 2032 (US$M)

Figure 23-56: Leading Competitors, Atrial & Ventricular Septal Defect Closure Device Market, Global, 2025

iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

Original primary research that consists of the most up-to-date market data
Strong foundation of quantitative and qualitative research
Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology

Explore Report Options

Report Summary

FREE

Select License Type

Overall, the global atrial septal defect closure device & ventricular septal defect closure device market was valued at $190.9 million in 2025. This is expected to increase over the forecast period at a CAGR of 1.8% to reach 215.7 million.